NASDAQ:BRKR - Bruker Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
$31.78 -0.47 (-1.46 %)
(As of 06/18/2018 04:00 PM ET)
Previous Close$32.25
Today's Range$31.67 - $32.08
52-Week Range$26.98 - $36.53
Volume327,366 shs
Average Volume580,694 shs
Market Capitalization$5.03 billion
P/E Ratio26.25
Dividend Yield0.50%
Beta1.17

About Bruker (NASDAQ:BRKR)

Bruker logoBruker Corporation manufactures and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates in two segments, Bruker Scientific Instruments, and Bruker Energy & Supercon Technologies. It offers life science tools based on magnetic resonance technology; life science mass spectrometry and ion mobility spectrometry systems; infrared spectroscopy and radiological/nuclear detectors for chemical, biological, radiological, nuclear, and explosive detection in emergency response, homeland security, and defense applications; and research, analytical, and process analysis instruments and solutions based on infrared and Raman molecular spectroscopy technologies. The company also provides X-ray instruments, atomic force microscopy instrumentation, fluorescence optical microscopy instruments, analytical tools for electron microscopes and X-ray metrology, and defect-detection equipment for semiconductor process control, as well as handheld, portable, and mobile X-ray fluorescence spectrometry instruments and spark optical emission spectroscopy systems. In addition, it offers superconducting and non-superconducting materials and devices. The company serves pharmaceutical, biotechnology and diagnostics, chemical, food and beverage, clinical, polymer, nanotechnology, semiconductor, and industrial companies; nonprofit laboratories; contract research organizations, academic institutions, medical schools, nonprofit or for-profit forensics, agriculture, food and beverage safety, environmental and clinical microbiology laboratories, hospitals, and government departments and agencies; and raw material manufacturers, and other businesses involved in materials analysis. It markets its products through direct sales forces, distributors, independent sales representatives, and other representatives. Bruker Corporation was founded in 1991 and is headquartered in Billerica, Massachusetts.

Receive BRKR News and Ratings via Email

Sign-up to receive the latest news and ratings for BRKR and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Analytical instruments
Sub-IndustryLife Sciences Tools & Services
SectorComputer and Technology
SymbolNASDAQ:BRKR
CUSIP11679410
Phone978-663-3660

Debt

Debt-to-Equity Ratio0.26
Current Ratio2.22
Quick Ratio1.29

Price-To-Earnings

Trailing P/E Ratio26.25
Forward P/E Ratio22.86
P/E Growth2.12

Sales & Book Value

Annual Sales$1.77 billion
Price / Sales2.81
Cash Flow$1.6239 per share
Price / Cash19.57
Book Value$4.72 per share
Price / Book6.73

Profitability

EPS (Most Recent Fiscal Year)$1.21
Net Income$78.60 million
Net Margins4.63%
Return on Equity27.04%
Return on Assets10.69%

Miscellaneous

Employees6,200
Outstanding Shares156,080,000

Bruker (NASDAQ:BRKR) Frequently Asked Questions

What is Bruker's stock symbol?

Bruker trades on the NASDAQ under the ticker symbol "BRKR."

How often does Bruker pay dividends? What is the dividend yield for Bruker?

Bruker announced a quarterly dividend on Tuesday, May 15th. Stockholders of record on Monday, June 4th will be paid a dividend of $0.04 per share on Friday, June 22nd. This represents a $0.16 annualized dividend and a dividend yield of 0.50%. The ex-dividend date of this dividend is Friday, June 1st. View Bruker's Dividend History.

How will Bruker's stock buyback program work?

Bruker announced that its board has authorized a share buyback plan on Sunday, June 4th 2017, which allows the company to repurchase $225,000,000.00 in outstanding shares, according to EventVestor. This repurchase authorization allows the company to repurchase shares of its stock through open market purchases. Stock repurchase plans are usually a sign that the company's board believes its shares are undervalued.

How were Bruker's earnings last quarter?

Bruker (NASDAQ:BRKR) released its quarterly earnings data on Thursday, May, 3rd. The medical research company reported $0.24 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.22 by $0.02. The medical research company had revenue of $431.70 million for the quarter, compared to the consensus estimate of $419.25 million. Bruker had a net margin of 4.63% and a return on equity of 27.04%. The company's quarterly revenue was up 12.2% on a year-over-year basis. During the same quarter last year, the business earned $0.19 earnings per share. View Bruker's Earnings History.

When is Bruker's next earnings date?

Bruker is scheduled to release their next quarterly earnings announcement on Thursday, August, 2nd 2018. View Earnings Estimates for Bruker.

What price target have analysts set for BRKR?

11 analysts have issued 12 month price targets for Bruker's stock. Their predictions range from $24.00 to $42.00. On average, they anticipate Bruker's stock price to reach $32.80 in the next year. View Analyst Ratings for Bruker.

Who are some of Bruker's key competitors?

Who are Bruker's key executives?

Bruker's management team includes the folowing people:
  • Dr. Frank H. Laukien, Chairman, CEO & Pres (Age 58)
  • Dr. Mark R. Munch Ph.D., Exec. VP, Pres of Bruker Nano Surfaces Division and Pres of Bruker Nano Group (Age 56)
  • Mr. Juergen Srega, Pres of Bruker Daltonics Division and Pres of Bruker CALID Group (Age 63)
  • Mr. Anthony L. Mattacchione, Former CFO & Sr. VP (Age 55)
  • Mr. Gerald N. Herman, VP, Interim CFO and Principal Accounting Officer & Corp. Controller

Has Bruker been receiving favorable news coverage?

Media coverage about BRKR stock has been trending somewhat positive recently, Accern reports. The research group rates the sentiment of media coverage by monitoring more than 20 million blog and news sources in real time. Accern ranks coverage of companies on a scale of -1 to 1, with scores closest to one being the most favorable. Bruker earned a news sentiment score of 0.08 on Accern's scale. They also gave media coverage about the medical research company an impact score of 47.03 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the company's share price in the immediate future.

Who are Bruker's major shareholders?

Bruker's stock is owned by a number of of institutional and retail investors. Top institutional shareholders include BlackRock Inc. (3.37%), Russell Investments Group Ltd. (0.95%), Victory Capital Management Inc. (0.88%), Boston Partners (0.83%), Millennium Management LLC (0.71%) and Dimensional Fund Advisors LP (0.61%). Company insiders that own Bruker stock include Frank H Laukien, Ingen Chris Van, Mark Munch, Richard A Packer and Richard Kniss. View Institutional Ownership Trends for Bruker.

Which institutional investors are selling Bruker stock?

BRKR stock was sold by a variety of institutional investors in the last quarter, including Millennium Management LLC, Sensato Investors LLC, Victory Capital Management Inc., New York State Common Retirement Fund, Massachusetts Financial Services Co. MA, Hsbc Holdings PLC, Citadel Advisors LLC and Teacher Retirement System of Texas. View Insider Buying and Selling for Bruker.

Which institutional investors are buying Bruker stock?

BRKR stock was bought by a variety of institutional investors in the last quarter, including Allianz Asset Management GmbH, Allianz Asset Management GmbH, Point72 Asset Management L.P., Old Mutual Global Investors UK Ltd., Carillon Tower Advisers Inc., Great Lakes Advisors LLC, BlackRock Inc. and GSA Capital Partners LLP. Company insiders that have bought Bruker stock in the last two years include Frank H Laukien and Richard A Packer. View Insider Buying and Selling for Bruker.

How do I buy shares of Bruker?

Shares of BRKR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Bruker's stock price today?

One share of BRKR stock can currently be purchased for approximately $31.78.

How big of a company is Bruker?

Bruker has a market capitalization of $5.03 billion and generates $1.77 billion in revenue each year. The medical research company earns $78.60 million in net income (profit) each year or $1.21 on an earnings per share basis. Bruker employs 6,200 workers across the globe.

How can I contact Bruker?

Bruker's mailing address is 40 Manning Road, Billerica MA, 01821. The medical research company can be reached via phone at 978-663-3660 or via email at [email protected]


MarketBeat Community Rating for Bruker (BRKR)

Community Ranking:  2.4 out of 5 (star star)
Outperform Votes:  458 (Vote Outperform)
Underperform Votes:  514 (Vote Underperform)
Total Votes:  972
MarketBeat's community ratings are surveys of what our community members think about Bruker and other stocks. Vote "Outperform" if you believe BRKR will outperform the S&P 500 over the long term. Vote "Underperform" if you believe BRKR will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 6/18/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.